Echocardiography to individualize treatment for hypertrophic cardiomyopathy.
Treatments for hypertrophic cardiomyopathy are largely selected based on patient symptoms and echocardiographic findings. Moreover, all the advanced treatments for heart failure symptoms depend on such imaging for planning and monitoring response to therapy. Risk of sudden death correlates with maximum left ventricular (LV) wall thickness. Massive LV thickening of 30 mm or more is an indication for primary prevention of sudden death with an implanted defibrillator. In this review, we will underscore potential pitfalls in echocardiographic diagnosis. Also we will review, a newly appreciated pathophysiologic mechanism in obstruction dynamic systolic dysfunction due to gradient.
Division of Cardiology, St Luke's-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, 1000 10th Ave, New York City, NY 10019, USA. msherrid@chpnet.org
Mark V
MV
Sherrid
Milla
M
Arabadjian
D058406:Cardiac Resynchronization Therapy / Q000379:methods*; D006348:Cardiac Surgical Procedures / Q000379:methods*; D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging / Q000628:therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004452:Echocardiography; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods*; D016896:Treatment Outcome
D002317:Cardiovascular Agents